Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 17.0B | 17.2B | 16.6B | 16.3B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 3.6B | 3.7B | 3.5B | 3.4B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 3.3B | 2.8B | 3.2B | 3.8B |
Tax provision | 746M | 586M | 697M | 775M |
Net income | 2.6B | 2.2B | 2.5B | 3.0B |
Basic EPS | 3.6 | 3.0 | 3.5 | 4.2 |
Diluted EPS | 3.6 | 3.0 | 3.5 | 4.2 |
Basic average shares | 701M | 703M | 708M | 716M |
Diluted average shares | 702M | 704M | 709M | 717M |
EBITDA | — | — | — | — |
Net income from continuing op. | 2.6B | 2.2B | 2.5B | 3.0B |
Minority interests | — | — | — | — |
Preferred stock dividends | 18M | 17M | 18M | 23M |